Adamis Pharmaceuticals Corp - FORM 10-K - EX-21.1 - SUBSIDIARIES - April 15, 2021

Attached files

file filename
10-K - ANNUAL REPORT - Adamis Pharmaceuticals Corpadmp-10k_123120.htm
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex32-2.htm
EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex32-1.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex31-2.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex31-1.htm
EX-23.2 - CONSENT OF MAYER HOFFMAN MCCANN P.C. - Adamis Pharmaceuticals Corpex23-2.htm
EX-23.1 - CONSENT OF BDO USA, LLP - Adamis Pharmaceuticals Corpex23-1.htm
EX-10.73 - PROMISSORY NOTE DATED MARCH 15, 2021 - Adamis Pharmaceuticals Corpex10-73.htm
EX-10.72 - LEASE AGREEMENT - Adamis Pharmaceuticals Corpex10-72.htm
EX-10.20 - FIRST AMENDMENT TO LEASE - Adamis Pharmaceuticals Corpex10-20.htm
EX-4.6 - DESCRIPTION OF CAPITAL STOCK - Adamis Pharmaceuticals Corpex4-6.htm
 

Adamis Pharmaceuticals Corporation 10-K

 

Exhibit 21.1

 

EXHIBIT 21.1

 

SUBSIDIARIES OF ADAMIS PHARMACEUTCALS CORPORATION

 

 

Name

 State of Incorporation
   
US Compounding, Inc. Arkansas
Biosyn, Inc. Pennsylvania
Adamis Corporation Delaware
Rhombus Pharmaceuticals Corporation Arkansas
   

 

 

 

 

   

 

 

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports